FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2038961641> ?p ?o ?g. }

• W2038961641 endingPage "100" @default.
• W2038961641 startingPage "94" @default.
• W2038961641 abstract "Gaucher disease, resulting from deficient lysosomal glucocerebrosidase (GC) activity, is the most common lysosomal storage disorder. Clinically important GC mutant enzymes typically have reduced specific activity and reduced lysosomal concentration, the latter due to compromised folding and trafficking. We and others have demonstrated that pharmacological chaperones assist variant GC folding by binding to the active site, stabilizing the native conformation of GC in the neutral pH environment of the endoplasmic reticulum (ER), enabling its trafficking from the ER to the Golgi and on to the lysosome. The mutated GC fold is generally stable in the lysosome after pharmacological chaperone dissociation, owing to the low pH environment for which the fold was evolutionarily optimized and the high substrate concentration, enabling GC to hydrolyze glucosylceramide to glucose and ceramide. The hypothesis of this study was that we could combine GC pharmacological chaperone structure−activity relationships from distinct chemical series to afford potent novel chaperones comprising a carbohydrate-like substructure that binds in the active site with a hydrophobic substructure that binds in a nearby pocket. We combined isofagomine and 2,5-anhydro-2,5-imino-d-glucitol active site binding substructures with hydrophobic alkyl adamantyl amides to afford novel small molecules with enhanced ability to increase GC activity in patient-derived fibroblasts. The cellular activity of N370S and G202R GC in fibroblasts is increased by 2.5- and 7.2-fold with isofagmine-based pharmacological chaperones N-adamantanyl-4-((3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)piperidin-1-yl)-butanamide (3) and N-adamantanyl-4-((3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)piperidin-1-yl)pentanamide (4), respectively, the best enhancements observed to date." @default.
• W2038961641 created "2016-06-24" @default.
• W2038961641 creator A5069437598 @default.
• W2038961641 creator A5081499831 @default.
• W2038961641 creator A5083272386 @default.
• W2038961641 creator A5086693798 @default.
• W2038961641 creator A5089827746 @default.
• W2038961641 date "2006-12-15" @default.
• W2038961641 modified "2023-10-16" @default.
• W2038961641 title "Isofagomine- and 2,5-Anhydro-2,5-imino-<scp>d</scp>-glucitol-Based Glucocerebrosidase Pharmacological Chaperones for Gaucher Disease Intervention" @default.
• W2038961641 cites W1517097867 @default.
• W2038961641 cites W1527172969 @default.
• W2038961641 cites W1597854169 @default.
• W2038961641 cites W1758125525 @default.
• W2038961641 cites W1831130622 @default.
• W2038961641 cites W1940027108 @default.
• W2038961641 cites W1965705234 @default.
• W2038961641 cites W1968758382 @default.
• W2038961641 cites W197265681 @default.
• W2038961641 cites W1982537903 @default.
• W2038961641 cites W1988511393 @default.
• W2038961641 cites W1991968375 @default.
• W2038961641 cites W2006892813 @default.
• W2038961641 cites W2007826813 @default.
• W2038961641 cites W2010595044 @default.
• W2038961641 cites W2014145818 @default.
• W2038961641 cites W2019261756 @default.
• W2038961641 cites W2019697237 @default.
• W2038961641 cites W2025837524 @default.
• W2038961641 cites W2026173779 @default.
• W2038961641 cites W2034118054 @default.
• W2038961641 cites W2048206189 @default.
• W2038961641 cites W2055570767 @default.
• W2038961641 cites W2057261483 @default.
• W2038961641 cites W2071562149 @default.
• W2038961641 cites W2080264145 @default.
• W2038961641 cites W2112126380 @default.
• W2038961641 cites W2124305857 @default.
• W2038961641 cites W2125281037 @default.
• W2038961641 cites W2135424735 @default.
• W2038961641 cites W2142115754 @default.
• W2038961641 cites W2147001430 @default.
• W2038961641 cites W2150199095 @default.
• W2038961641 cites W2163527490 @default.
• W2038961641 cites W2165093984 @default.
• W2038961641 cites W2233399397 @default.
• W2038961641 cites W2285361820 @default.
• W2038961641 cites W2334691957 @default.
• W2038961641 cites W2404954668 @default.
• W2038961641 cites W2952806719 @default.
• W2038961641 cites W3205141978 @default.
• W2038961641 cites W4252969769 @default.
• W2038961641 doi "https://doi.org/10.1021/jm060677i" @default.
• W2038961641 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2543937" @default.
• W2038961641 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17201413" @default.
• W2038961641 hasPublicationYear "2006" @default.
• W2038961641 type Work @default.
• W2038961641 sameAs 2038961641 @default.
• W2038961641 citedByCount "133" @default.
• W2038961641 countsByYear W20389616412012 @default.
• W2038961641 countsByYear W20389616412013 @default.
• W2038961641 countsByYear W20389616412014 @default.
• W2038961641 countsByYear W20389616412015 @default.
• W2038961641 countsByYear W20389616412016 @default.
• W2038961641 countsByYear W20389616412017 @default.
• W2038961641 countsByYear W20389616412019 @default.
• W2038961641 countsByYear W20389616412020 @default.
• W2038961641 countsByYear W20389616412022 @default.
• W2038961641 countsByYear W20389616412023 @default.
• W2038961641 crossrefType "journal-article" @default.
• W2038961641 hasAuthorship W2038961641A5069437598 @default.
• W2038961641 hasAuthorship W2038961641A5081499831 @default.
• W2038961641 hasAuthorship W2038961641A5083272386 @default.
• W2038961641 hasAuthorship W2038961641A5086693798 @default.
• W2038961641 hasAuthorship W2038961641A5089827746 @default.
• W2038961641 hasBestOaLocation W20389616412 @default.
• W2038961641 hasConcept C119062480 @default.
• W2038961641 hasConcept C139447449 @default.
• W2038961641 hasConcept C142724271 @default.
• W2038961641 hasConcept C158617107 @default.
• W2038961641 hasConcept C181199279 @default.
• W2038961641 hasConcept C185592680 @default.
• W2038961641 hasConcept C2775962898 @default.
• W2038961641 hasConcept C2776792218 @default.
• W2038961641 hasConcept C2780216420 @default.
• W2038961641 hasConcept C2780674200 @default.
• W2038961641 hasConcept C41183919 @default.
• W2038961641 hasConcept C55493867 @default.
• W2038961641 hasConcept C61397870 @default.
• W2038961641 hasConcept C71240020 @default.
• W2038961641 hasConcept C71924100 @default.
• W2038961641 hasConceptScore W2038961641C119062480 @default.
• W2038961641 hasConceptScore W2038961641C139447449 @default.
• W2038961641 hasConceptScore W2038961641C142724271 @default.
• W2038961641 hasConceptScore W2038961641C158617107 @default.
• W2038961641 hasConceptScore W2038961641C181199279 @default.
• W2038961641 hasConceptScore W2038961641C185592680 @default.
• W2038961641 hasConceptScore W2038961641C2775962898 @default.

• next